Spineway's General Meeting Approves Resolutions

On April 2, 2026, Spineway held its Combined General Meeting at their headquarters in Ecully. All shareholders were represented, with SELARL TULIER POLGE ALIREZAI acting as ad hoc representative for defaulting ones. The meeting reached a quorum with 35,544,391 shares, accounting for 100% of voting rights, allowing proceedings to commence smoothly.

The shareholders approved all proposed resolutions except Resolution No. 17, which followed the recommendation of the Board of Directors. CEO Stéphane Le Roux expressed gratitude for shareholder participation and support, affirming confidence in Spineway's growth strategy. Details from the meeting can be accessed on Spineway's website.

Spineway, a company specializing in spinal treatment technologies, anticipates its next financial event with the announcement of first-quarter 2026 revenue on April 30, 2026.